Skip to main content
Log in

Suboptimal use of statins for secondary cardiovascular prevention: a “planetary” issue

  • IM - COMMENTARY
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Huang BT, Peng Y, Huang FY et al (2017) Trends in prescribing rate of statins at discharge and modifiable factors in patients with atherosclerotic cardiovascular disease. Intern Emerg Med. doi:10.1007/s11739-017-1694-9 (Epub ahead of print)

    Google Scholar 

  2. Maddox TM, Borden WB, Tang F et al (2014) Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry. J Am Coll Cardiol 64:2183–2192

    Article  PubMed  Google Scholar 

  3. Shah NS, Huffman MD, Ning H, Lloyd-Jones DM (2015) Trends in myocardial infarction secondary prevention: The National Health and Nutrition Examination Surveys (NHANES), 1999–2012. J Am Heart Assoc 4:e001709

    Article  PubMed  PubMed Central  Google Scholar 

  4. Subherwal S, Patel MR, Kober L et al (2012) Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains. Circulation 126:1345–1354

    Article  PubMed  Google Scholar 

  5. Guglielmi V, Bellia A, Pecchioli S et al (2017) Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: a real-world evidence study in primary care. Atherosclerosis 263:36–41

    Article  CAS  PubMed  Google Scholar 

  6. Cholesterol Treatment Trialists’ (CTT) Collaboration, Baigent C, Blackwell L, Emberson J et al (2010) Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376:1670–1681

    Article  Google Scholar 

  7. Gupta A, Thompson D, Whitehouse A et al (2017) Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase. Lancet 389:2473–2481

    Article  CAS  PubMed  Google Scholar 

  8. Catapano AL, Graham I, De Backer G et al (2016) ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Developed with the special contribution of the european association for cardiovascular prevention & rehabilitation (EACPR). Eur Heart J 37:2999e3058

    Article  Google Scholar 

  9. Drozda JP Jr, Ferguson TB Jr, Jneid H et al (2016) 2015 ACC/AHA focused update of secondary prevention lipid performance measures: a report of the American College of Cardiology/American Heart Association Task Force on performance measures. J Am Coll Cardiol 67:558–587

    Article  PubMed  Google Scholar 

  10. Gæde P, Vedel P, Larsen N et al (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383–393

    Article  PubMed  Google Scholar 

  11. Cramer JA, Mattson RH, Prevey ML et al (1989) How often is medication taken as prescribed? A novel assessment technique. JAMA 261:3273–3277

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alfonso Bellia.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Statement of human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bellia, A., Della-Morte, D. & Lauro, D. Suboptimal use of statins for secondary cardiovascular prevention: a “planetary” issue. Intern Emerg Med 12, 1091–1092 (2017). https://doi.org/10.1007/s11739-017-1749-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-017-1749-y

Keywords

Navigation